Posted on 4/2/18
Target Vs. TJX: Which To Buy During The Next Downturn?
IntroductionIn 2018, I began publishing a series of articles that focus on how far certain popular stocks that have recently experienced all-time highs might fall during . . .
Posted on 3/31/18
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., March 30, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine . . .
Posted on 3/30/18
Professional Physical Therapy Scores a Perfect Ten!
Professional Physical Therapy Expands its Reach in Massachusetts with the Acquisition of Teamwork Physical Therapy, plus new Openings in Allston and Newton Professional Physical Therapy, a . . .
Posted on 3/30/18
Blue Monarch Launches Leaping Bunny Certified Skin Care Line
52Launch and Blue Monarch are excited to announce a new line of skin care and beauty products that are "Leaping Bunny Certified," the gold-standard in cruelty-free . . .
Posted on 3/30/18
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BOSTON, March 30, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline . . .
Posted on 3/29/18
Bone Biologics Completes $500,000 of Financing
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics (OTCQB: BBLG), a developer of orthobiologic products for domestic and international spine fusion markets, announced today the completion of $500,000 funding with . . .
Posted on 3/29/18
Pharma and Biotech Data Science Pioneers to Share What’s Next at Bio-IT World
BOSTON, March 29, 2018 (GLOBE NEWSWIRE) -- Cambridge Healthtech Institute, a division of Cambridge Innovation Institute, is pleased to once again invite the community to join . . .
Posted on 3/29/18
Forget Merck: Novavax, Inc. Is a Better Vaccine Stock
Could Novavax, Inc. (NASDAQ:NVAX) be a better vaccine stock than Merck (NYSE:MRK)? I think so.That might sound crazy. After all, Novavax is tiny and unproven. It's . . .
Posted on 3/29/18
Don't Get Greedy With Cara Therapeutics, Inc. Stock
Cara Therapeutics (NASDAQ:CARA) could be on the verge of having its best year ever in 2018. My colleague Sean Williams ranks Cara as one of the . . .
Posted on 3/28/18
Peak Physical Therapy & Sports Performance Forms Alliance with TRG Performance Training
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and sports medicine specialties, today . . .
Posted on 3/28/18
Homology Medicines Prices IPO
Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the pricing of its initial public offering of 9,000,000 shares of common stock at a . . .
Posted on 3/27/18
Leap Therapeutics Closes Public Offering of Common Stock
CAMBRIDGE, Mass., March 27, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closing . . .
Posted on 3/26/18
FORMA Therapeutics Collaborates with Arpeggio Biosciences
WATERTOWN, Mass. & BOULDER, Colo.--(BUSINESS WIRE)--FORMA Therapeutics and Arpeggio Biosciences today announced a collaboration to utilize Arpeggio Biosciences’ proprietary technology to supplement FORMA’s analysis of the . . .
Posted on 3/26/18
Macrolide Pharmaceuticals Announces Up to $6.8 Million Award
WATERTOWN, Mass.--(BUSINESS WIRE)--Macrolide Pharmaceuticals today announced it has been granted a CARB-X award of up to $6.8M to support the development of a novel fully synthetic, . . .
Posted on 3/26/18
American Renal Associates Holdings Announces Launch of Secondary Public Offering of Common Stock
BEVERLY, Mass.--(BUSINESS WIRE)--American Renal Associates Holdings, Inc. (NYSE: ARA), a provider of outpatient dialysis services, today announced the launch of an underwritten public offering of 5,000,000 . . .
Posted on 3/26/18
NovaQuest Capital Management Acquires CutisPharma
CutisPharma, Inc., a specialty pharmaceutical company that for two decades has been the industry leader in providing innovative solutions to pharmacists, with its recently approved 505(b)(2) . . .
Posted on 3/26/18
Gilead Sciences' Investors Better Watch This Regeneron-Alnylam Deal
The chronic liver disease nonalcoholic steatohepatitis (NASH) is supposed to be Gilead Sciences' (NASDAQ:GILD) next hepatitis C -- a disease that doubled Gilead's sales almost overnight. . . .
Posted on 3/26/18
Better Buy: Gilead Sciences, Inc. vs. Biogen Inc.
Gilead Sciences, Inc. (NASDAQ:GILD) and Biogen Inc. (NASDAQ:BIIB) enjoyed the admiration of investors for years as two of the brightest stars in the biotech universe. However, . . .
Posted on 3/25/18
Massachusetts Doctor Opens New MDVIP-Affiliated Primary Care Practice
MDVIP, the national leader in affordable personalized healthcare, announced today that Harveen Singh, M.D., has opened an MDVIP-affiliated primary care practice in Framingham, Massachusetts. Board certified . . .
Posted on 3/25/18
Akebia Therapeutics Prices Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 3/25/18
Leap Therapeutics Prices $14 Million Public Offering of Common Stock
CAMBRIDGE, Mass., March 23, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the pricing . . .
Posted on 3/25/18
Surface Oncology on Deck for IPO
Cambridge, MA-based Surface Oncology (OTC:SURF) is approaching its U.S. debut with the filing of an S-1.The clinical-stage immuno-oncology firm develops next-generation cancer therapies that it says . . .
Posted on 3/23/18
Better Buy: Celgene Corporation vs. Biogen Inc.
It's been a great decade to own stocks in general, but those of you who bought Celgene Corporation (NASDAQ:CELG) or Biogen, Inc. (NASDAQ:BIIB) back in 2008 . . .
Posted on 3/23/18
Akebia Therapeutics Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 3/22/18
Leap Therapeutics Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., March 22, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it . . .

